作者:
Peer, C.J. [1]
;
Brown, J.L. [2]
;
Martin, T.J. [3]
;
Roth, J. [4]
;
Spencer, S.D. ;
Brassil, P. ;
McNeill, K.A. ;
Kreisl, T.N. ;
Fine, H.A. ;
Figg, W.D.
作者单位:
AstraZeneca Pharmaceuticals, Waltham, MA, United States
[1]
Clinical Pharmacology Program, Office of the Clinical Director, National Cancer Institute, Bethesda, MD, United States
[2]
Neuro-Oncology Branch, National Cancer Institute, Bethesda, MD, United States
[3]
Division of Pharmaceutical Sciences, School of Pharmacy, Fairleigh Dickinson University, Florham Park, NJ, United States
[4]
发布时间
2014-02-19